无抽搐电休克联合利培酮对精神分裂症患者的影响  

Influence of modified electroconvulsive therapy combined with Risperidone on patients with schizophrenia

作　　者：姜彬贵 JIANG Bin-gui(Department of Psychiatry,the Third People′s Hospital of Ganzhou City,Jiangxi Province,Ganzhou 341000,China)

机构地区：[1]江西省赣州市第三人民医院精神科,江西赣州341000

出　　处：《中国当代医药》2020年第16期75-77,共3页China Modern Medicine

摘　　要：目的探讨无抽搐电休克联合利培酮对精神分裂症患者的影响。方法选取我院2017年1月~2019年6月我院收治的80例精神分裂症患者作为研究对象,按照随机数字表法分为对照组(40例)与观察组(40例)。对照组给予利培酮口服治疗,观察组在对照组的基础上联合使用无抽搐电休克治疗。比较两组治疗前、治疗28 d后的阳性与阴性症状量表(PANSS)、韦氏记忆量表(WMS)评分情况。结果观察组治疗后的PANSS阳性评分、阴性评分均低于对照组,WMS评分高于对照组,差异有统计学意义(P<0.05)。结论无抽搐电休克联合利培酮治疗精神分裂症患者能降低患者PANSS评分,提高WMS评分,值得临床推广使用。Objective To investigate the influence of modified electroconvulsive therapy combined with Risperidone on patients with schizophrenia.Methods A total of 80 patients with schizophrenia who admitted in the hospital from January 2017 to June 2019 were selected as research subjects,and they were divided into the control group(40 cases)and the observation group(40 cases)according to random number table methods.The control group orally took Risperidone,and the observation group was treated with modified electroconvulsive therapy on the based of the control group.The positive and negative syndrome scale(PANSS)and Wechsler memory scale(WMS)scores of the two groups before treatment and after treatment for 28 d were compared.Results After treatment,the PANSS positive score and negative score of the observation group were lower than those of the control group,and the WMS score of the observation group was higher than that of the control group,and the differences were statistically significant(P<0.05).Conclusion Modified electroconvulsive therapy combined with Risperidone in the treatment of patients with schizophrenia can decrease PANSS score and increase WMS score,which is worthy of clinical promotion and application.

关 键 词：精神分裂症 无抽搐电休克 利培酮 阳性与阴性症状量表评分 韦氏记忆量表评分 

分 类 号：R749.3[医药卫生—神经病学与精神病学]